Allogene raises $324M in year's largest biotech IPO on NASDAQ

Less than a year after it was founded, cell therapy Allogene Therapeutics Inc. (NASDAQ:ALLO) raised $324 million late Wednesday in the largest IPO by a biotech on NASDAQ thus far in 2018. Trading is to begin Thursday.